1-4 of 4
Heather Herren
Close
Sort by
Journal Articles

Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies

Jacqueline Poston, Siobhan Brown, Amy S Ginsburg, Anton Ilich, Heather Herren, Nahed El Kassar, Christopher Edward Jensen, Darrell J Triulzi, Nigel S. Key, Susanne May, Terry B Gernsheimer
Journal: Blood
Blood (2023) 142 (Supplement 1): 2667.
https://doi.org/10.1182/blood-2023-186654
Published: 2023
Journal Articles

Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

Clinical Trials & Observations
Terry B. Gernsheimer, Siobhan P. Brown, Darrell J. Triulzi, Nigel S. Key, Nahed El Kassar, Heather Herren, Jacqueline N. Poston, Michael Boyiadzis, Brandi N. Reeves, Subodh Selukar, Monica B. Pagano, Scott Emerson, Susanne May
Journal: Blood
Blood (2022) 140 (11): 1254–1262.
https://doi.org/10.1182/blood.2022016308
Published: 2022
Includes: Supplemental data
Journal Articles

Absence of Hyperactivation of Fibrinolysis Explains the Lack of Hemostatic Efficacy of Prophylactic Tranexamic Acid (TXA) in Hypoproliferative Thrombocytopenia

Anton Ilich, Terry B. Gernsheimer, Darrell J Triulzi, Heather Herren, Siobhan P Brown, Lori A Holle, Andrew T Lucas, Nahed El Kassar, Alisa S. Wolberg, Susanne May, Nigel S Key
Journal: Blood
Blood (2021) 138 (Supplement 1): 2094.
https://doi.org/10.1182/blood-2021-146898
Published: 2021
Journal Articles

Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial

Terry B. Gernsheimer, MD, Siobhan P Brown, PhD, Darrell J Triulzi, MD, Nigel S. Key, MD, Nahed El Kassar, MD PhD, Heather Herren, RN, MPH, Susanne May, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-138920
Published: 2020